In the agency’s study, researchers looked at 1566 patients who received antibiotics and found that 55.9% shouldn’t have received them based on practice guidelines.
Studies have shown patients with antibiotic-resistant infections are at an increased risk of worse clinical outcomes, such as severe disease and death, compared with patients with infections that can be treated with antibiotics.
This may be due to significantly longer hospital stays, high risk of treatment failure and increased risk of undergoing surgery, Goff said. According to the CDC, more than 35000 people die from antibiotic-resistant infections in the U.S. each year.
They’re not only deadly, but costly. According to a January report by the CDC and the University of Utah, six multi-drug resistant pathogens are estimated to cost the U.S. more than $4.6 billion annually.
Comments are closed.